P0772 : Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: Interim results of a multicenter compassionate use program

Autor: Welzel, T.M., Herzer, K., Ferenci, P., Petersen, J., Gschwantler, M., Cornberg, M., Berg, T., Spengler, U., Weiland, O., Van der Valk, M., Klinker, H., Rockstroh, J., Ingiliz, P., Peck-Radosavljevic, M., Jimenez-Exposito, M.J., Zeuzem, S.
Zdroj: In Journal of Hepatology April 2015 62 Supplement 2:S619-S620
Databáze: ScienceDirect